Related Experiment Video
Updated: May 8, 2026
Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment
Published on: January 24, 2020
Multivariate statistical data analysis as a tool to analyze ex vivo expansion dynamics of cytokine-induced killer
Cristina Zanon1, Matteo Stocchero, Elena Albiero
1Advanced Cellular Therapy Laboratory, Department of Cell Therapy and Hematology, San Bortolo Hospital, Vicenza, 36100, Italy.
Insights
Multivariate statistical analysis can predict the optimal harvesting day for cytokine-induced killer (CIK) cell expansion, improving immunotherapy efficacy. This method identifies key cell markers to ensure a high percentage of therapeutic CIK cells for cancer treatment.
Area of Science:
- Immunology
- Biotechnology
- Statistical Analysis
Background:
- Cytokine-induced killer (CIK) cells are a promising immunotherapy for hematological malignancies due to their antitumor effects.
- Maximizing the percentage of CD3(+) CD56(+) effector cells is crucial for in vivo efficacy but is highly variable.
- Multivariate statistical data analysis (MVDA) was used to analyze CIK cell expansions and predict optimal harvesting times.
Purpose of the Study:
- To develop mathematical models for predicting CIK cell expansion fate.
- To identify the optimal harvesting day for CIK cell expansion to maximize therapeutic potential.
- To optimize CIK cell expansion processes for enhanced immunotherapy.
Main Methods:
- Retrospective analysis of 30 CIK cell expansions using cytofluorimetric data.
- Application of multivariate batch statistical process control to monitor cell expansion.
- Utilizing orthogonal projections to latent structures (OPLS) to predict CIK cell percentages.
Main Results:
- A highly predictive regression model was developed to estimate CD3(+) CD56(+) cell counts during culture.
- Optimal CIK cell concentration was reached by day 17 in 36.7% of expansions and by day 21 in the remainder.
- Key predictive variables identified were NK cells at day 0, cytotoxic T-lymphocytes (CTLs) at day 4, and CIK cells at day 7.
- "Good batches" with ≥40% CD3(+) CD56(+) cells were associated with high CTLs at day 4 and CIK cells at day 7.
Conclusions:
- MVDA enables optimization of CIK cell expansion by determining the ideal harvesting day.
- CTLs and CIK cells show predictive value for successful CIK expansion.
- This approach can enhance the efficacy of CIK cell-based immunotherapy.
Background:
Cytokine-induced killer (CIK) cells, obtained after mononucleated cell stimulation with interferon-γ, interleukin-2, and anti-CD3 antibody, are constituted by CD3(+) CD56(+) (CIK) cells and a minority of natural killer (NK; CD3(-) CD56(+) ) cells and T-lymphocytes (CD3(+) CD56(-) ) with antitumor effect against hematological malignancies, thus representing a promising immunotherapy strategy. To ensure in vivo antitumor activity it is mandatory to maximize the percentage of CD3(+) 56(+) effector cells, which is highly variable depending on the starting sample and the harvesting day. Based on cytofluorimetric data, we have retrospectively applied multivariate statistical data analysis (MVDA) to 30 expansions building mathematical models able to predict the expansion fate and the optimal CIK harvesting day.
Methods:
Cell phenotype was monitored during culture; multivariate batch statistical process control was applied to monitor cell expansion and orthogonal projections to latent structures to predict CIK percentage.
Results:
Ten expansions had CD3(+) CD56(+) cells ≥ 40% (good batches) and 20 had CD3(+) CD56(+) cells ≤ 40%. In 36.7%, CD3(+) CD56(+) cells reached the highest concentration at day 17 and the others at day 21. We built a highly predictive regression model for estimating CD3(+) CD56(+) cells during culture. Three variables resulted highly informative: NK % at day 0, cytotoxic T-lymphocytes % (CTLs, CD3(+) CD8(+) ) at day 4, and CIK % at day 7. "Good batches" are characterized by a high percentage of CTLs and CD3(+) CD56(+) cells at day 4 and day 7, respectively.
Conclusion:
By applying MVDA it is possible to optimize CIK expansion, deciding the optimal cell harvesting day. A predictive role for CTL and CIK was evidenced.
